HR Execs on the Move

rl Solutions

www.rl-solutions.com

 
rl Solutions is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Hexagon Labs

Hexagon Labs is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HonorHealth

HonorHealth is both a name and call to action. HonorHealth emphasizes the historic trustworthiness and integrity of our organization`s brand. It demonstrates our respect and dedication to delivering the highest quality care in a personal and easy manner. We are committed to providing the right care at the right time at the right place. We continue to engage our communities in wellness. We make it easier than ever for you to get the personalized care you need in a way that works for you. With more than 3,000 expert physicians, 10,000 dedicated employees, and 3,000 caring volunteers, HonorHealth continues to strengthen our communities, making sure that everyone has access to quality healthcare.

Infinata

Infinata is a Norwood, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vets First Choice

We are the nation`s largest veterinary partner-pharmacy providing veterinarians with a custom online store so they can offer the best home delivery service for their clients. We offer pet owners a way to shop online with their own veterinarian in a safe and secure web store for their pet. Behind the scenes, we are the veterinarian`s fully-licensed and accredited veterinary pharmacy. We have direct partnerships with all of the manufacturers--so we don`t just guarantee that the products “are the same”...we 100% guarantee that all products have been handled properly to maintain their quality. That`s a big difference when it comes to the safety of a pet.

Imagin Medical

Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.